Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | Director | October 31, 2022 | November 01, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date October 31, 2022 · Filed November 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,709 |
Ending reported balance
After 2022-10-31 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-10-31 · Sale · Disposed 14,000 · Balance 14,709 F1: This transaction was executed in multiple trades at prices ranging from $25.89 to $26.135. The price reported above reflects the weighted average price. Row 2 · 2022-10-31 · Exercise / conversion · Acquired 7,000 · Balance 21,709 Row 3 · 2022-10-31 · Exercise / conversion · Acquired 7,000 · Balance 28,709 |
| Non-Employee Director Stock Option GrantSEC Table II · derivative / convertible security · Conversion / exercise price $24.21 · Expires 2028-05-17 | Direct | 0 |
Reported balance
After 2022-10-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-10-31 · Exercise / conversion · Disposed 7,000 · Balance 0 |
| Non-Employee Director Stock Option GrantSEC Table II · derivative / convertible security · Conversion / exercise price $18.70 · Expires 2027-05-18 | Direct | 0 |
Reported balance
After 2022-10-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-10-31 · Exercise / conversion · Disposed 7,000 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $25.89 to $26.135. The price reported above reflects the weighted average price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2022 Filed Nov 1, 2022 15:35 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 7,000 | $0.00 Strike: $18.70 | $0.00 |
DisclosureSEC source: 0001562180-22-007394 · primarydocument.xml · derivative · entry 5 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 15:35 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 7,000 | $0.00 Strike: $24.21 | $0.00 |
DisclosureSEC source: 0001562180-22-007394 · primarydocument.xml · derivative · entry 4 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2028-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 15:35 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 7,000 | $24.21 | $169,470.00 |
DisclosureSEC source: 0001562180-22-007394 · primarydocument.xml · nonDerivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 15:35 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 7,000 | $18.70 | $130,900.00 |
DisclosureSEC source: 0001562180-22-007394 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 15:35 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 14,000 | $26.04 | $364,547.40 |
DisclosureSEC source: 0001562180-22-007394 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,709 F1 · price: This transaction was executed in multiple trades at prices ranging from $25.89 to $26.135. The price reported above reflects the weighted average price. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:42 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 7,000 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006799 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:42 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 7,000 | $36.23 | $253,642.90 |
DisclosureSEC source: 0001562180-21-006799 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,709 F1 · price: This transaction was executed in multiple trades at prices ranging from $36.15 to $36.30. The price reported above reflects the weighted average price. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:42 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 7,000 | $15.74 | $110,180.00 |
DisclosureSEC source: 0001562180-21-006799 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 19:56 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 7,000 | $0.00 Strike: $17.46 | $0.00 |
DisclosureSEC source: 0001562180-21-006693 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 19:56 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 7,000 | $35.19 | $246,297.80 |
DisclosureSEC source: 0001562180-21-006693 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,709 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.09 to $35.23. The price reported above reflects the weighted average price. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 19:56 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 7,000 | $17.46 | $122,220.00 |
DisclosureSEC source: 0001562180-21-006693 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:16 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 2,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003702 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,709 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 18:02 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 7,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001562180-21-000898 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2024-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 18:02 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 7,000 | $33.90 | $237,286.70 |
DisclosureSEC source: 0001562180-21-000898 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,864 F1 · price: This transaction was executed in multiple trades at prices ranging from $33.82 to $33.94. The price reported above reflects the weighted average sale price. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 18:02 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 7,000 | $14.30 | $100,100.00 |
DisclosureSEC source: 0001562180-21-000898 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 15:41 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 7,000 | $0.00 Strike: $14.30 | $0.00 |
DisclosureSEC source: 0001562180-20-006538 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2024-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 15:41 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 7,000 | $28.06 | $196,389.20 |
DisclosureSEC source: 0001562180-20-006538 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,864 F1 · price: This transaction was executed in multiple trades at prices ranging from $28.04 to $28.08. The price reported above reflects the weighted average sale price. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 15:41 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 7,000 | $14.30 | $100,100.00 |
DisclosureSEC source: 0001562180-20-006538 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:22 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003904 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,864 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 22:29 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 12,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0001562180-20-000850 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2023-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are fully vested. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 22:29 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 12,000 | $30.06 | $360,680.40 |
DisclosureSEC source: 0001562180-20-000850 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,803 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.0469 to $30.075. The price reported above reflects the weighted average price. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 22:29 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 12,000 | $12.37 | $148,380.00 |
DisclosureSEC source: 0001562180-20-000850 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2019 Filed May 20, 2019 11:45 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-002982 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,803 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-employee Director Stock Option (Right to buy) · Derivative | 12,000 | $11.20 Strike: $11.20 | $134,340.00 |
DisclosureSEC source: 0001562180-19-000654 · primarydocument.xml · derivative · entry 5 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2022-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-employee Director Stock Option (Right to buy) · Derivative | 12,000 | $15.86 Strike: $15.86 | $190,260.00 |
DisclosureSEC source: 0001562180-19-000654 · primarydocument.xml · derivative · entry 4 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2021-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 24,000 | $21.40 | $513,506.40 |
DisclosureSEC source: 0001562180-19-000654 · primarydocument.xml · nonDerivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,400 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.375 to $21.435. The price reported above reflects the weighted average price. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 12,000 | $15.86 | $190,260.00 |
DisclosureSEC source: 0001562180-19-000654 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 12,000 | $11.20 | $134,340.00 |
DisclosureSEC source: 0001562180-19-000654 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2018 Filed May 18, 2018 00:45 UTC | GENTEX CORP GNTX · Entity 3954 | GrantNon-Employee Director Stock Option Grant · Derivative | 7,000 | $24.21 Strike: $24.21 | $169,470.00 |
DisclosureSEC source: 0001562180-18-002559 · primarydocument.xml · derivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2028-05-17 Read SEC document |
| January 30, 2018 Filed Jan 31, 2018 21:47 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 12,000 | $10.56 Strike: $10.56 | $126,720.00 |
DisclosureSEC source: 0001562180-18-000499 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2018 Filed Jan 31, 2018 21:47 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 12,000 | $23.40 | $280,776.00 |
DisclosureSEC source: 0001562180-18-000499 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,400 F1 · price: This transaction was executed in multiple trades at prices ranging from $23.30 to $23.43. The price reported above reflects the weighted average price. Read SEC document |
| January 30, 2018 Filed Jan 31, 2018 21:47 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 12,000 | $10.56 | $126,720.00 |
DisclosureSEC source: 0001562180-18-000499 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2017 Filed May 22, 2017 13:00 UTC | GENTEX CORP GNTX · Entity 3954 | GrantNon-Employee Director Stock Option Grant · Derivative | 7,000 | $18.70 Strike: $18.70 | $130,900.00 |
DisclosureSEC source: 0001562180-17-002028 · primarydocument.xml · derivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2027-05-18 Read SEC document |
| October 25, 2016 Filed Oct 26, 2016 17:11 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 12,000 | $9.67 Strike: $9.67 | $116,040.00 |
DisclosureSEC source: 0001562180-16-003279 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2018-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2016 Filed Oct 26, 2016 17:11 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 12,000 | $16.78 | $201,351.60 |
DisclosureSEC source: 0001562180-16-003279 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,400 Read SEC document |
| October 25, 2016 Filed Oct 26, 2016 17:11 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 12,000 | $9.67 | $116,040.00 |
DisclosureSEC source: 0001562180-16-003279 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.